French drug price cuts loom in €10bn savings plan
This article was originally published in Scrip
Executive Summary
The French pharmaceutical industry is again under the hammer after the parliament passed a package of measures including proposals to slice €10bn of healthcare spending over the 2015-17 period, €3.5bn of which will affect medicines, and probably medical devices, in the form of selected price cuts, together with moves to increase the market share of generics.